NASDAQ:AEMD

Aethlon Medical Stock Insider Trading

Healthcare > Medical - Devices

Buy AEMD

*Your capital is at risk

$2.10

-0.110 (-4.98%)

At Close: Jun 03, 2026

Aethlon Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 89.54. In total, the insiders bought 2.64M and sold 251.37K AEMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	89.54
● Buy	2.64M shares
● Sell	251.37K shares
32% Buy Activity Moderate Positive Correlation
Buy Signal High Confidence Apr 17, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 89.54. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 90.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 17, 2026 Buy	Common Stock A-Award	Broenniman Edward G Director	Director	21 815 Value: $50.0K
Apr 17, 2026 Buy	Common Stock A-Award	Shah Chetan Director	Director	21 815 Value: $50.0K
Apr 17, 2026 Buy	Common Stock A-Award	Rossetti Angela Director	Director	21 815 Value: $50.0K
Apr 17, 2026 Buy	Common Stock A-Award	Gikakis Nicolas Director	Director	21 815 Value: $50.0K
Mar 31, 2026 Sell	Common Stock F-InKind	Shah Chetan Director	Director	178 Value: $390
Mar 31, 2026 Sell	Common Stock F-InKind	Gikakis Nicolas Director	Director	178 Value: $390
Mar 31, 2026 Sell	Common Stock F-InKind	Broenniman Edward G Director	Director	89 Value: $195
Dec 31, 2025 Sell	Common Stock F-InKind	Broenniman Edward G Director	Director	89 Value: $247
Dec 31, 2025 Sell	Common Stock F-InKind	Shah Chetan Director	Director	179 Value: $496
Dec 31, 2025 Sell	Common Stock F-InKind	Gikakis Nicolas Director	Director	179 Value: $496
Sep 30, 2025 Sell	Common Stock F-InKind	Shah Chetan Director	Director	1 786 Value: $1K
Sep 30, 2025 Sell	Common Stock F-InKind	Gikakis Nicolas Director	Director	1 786 Value: $1K
Sep 30, 2025 Sell	Common Stock F-InKind	Broenniman Edward G Director	Director	893 Value: $669
Sep 30, 2025 Sell	Common Stock F-InKind	Broenniman Edward G Director	Director	893 Value: $669
Sep 30, 2025 Sell	Common Stock F-InKind	Gikakis Nicolas Director	Director	1 786 Value: $1K
Sep 30, 2025 Sell	Common Stock F-InKind	Shah Chetan Director	Director	1 786 Value: $1K
Jun 30, 2025 Sell	Common Stock F-InKind	Broenniman Edward G Director	Director	893 Value: $1K
Jun 30, 2025 Sell	Common Stock F-InKind	Gikakis Nicolas Director	Director	1 786 Value: $2K
Jun 30, 2025 Sell	Common Stock F-InKind	Shah Chetan Director	Director	1 786 Value: $2K
Jun 30, 2025 Sell	Common Stock F-InKind	Shah Chetan Director	Director	1 786 Value: $2K
Jun 30, 2025 Sell	Common Stock F-InKind	Gikakis Nicolas Director	Director	1 786 Value: $2K
Jun 30, 2025 Sell	Common Stock F-InKind	Broenniman Edward G Director	Director	893 Value: $1K
Apr 23, 2025 Buy	Common Stock A-Award	Gikakis Nicolas Director	Director	142 857 Value: $50.0K
Apr 23, 2025 Buy	Common Stock A-Award	Rossetti Angela Director	Director	142 857 Value: $50.0K
Apr 23, 2025 Buy	Common Stock A-Award	Broenniman Edward G Director	Director	142 857 Value: $50.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AETHLON MEDICAL

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc....

Read Full Profile Here